Doxazosin reduces cell proliferation and increases collagen fibers in rat prostatic lobes

Cell and Tissue Research

Volumn 332, Issue 1, 2008, Pages 171-183

  Justulin Jr , Luis A ^a   Delella, Flavia K ^a   Felisbino, Sérgio L ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Apoptosis; Cell proliferation; Collagen; Doxazosin; Prostate; Rat (Wistar, adult); Smooth muscle cell

Indexed keywords

COLLAGEN FIBER; CYCLINE; DOXAZOSIN MESYLATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; RAT; SMOOTH MUSCLE FIBER; STEREOLOGY; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; APOPTOSIS; BODY WEIGHT; CELL PROLIFERATION; COLLAGEN; DOXAZOSIN; EPITHELIAL CELLS; IN SITU NICK-END LABELING; MALE; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 41049086678     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0559-3     Document Type: Article

References (50)

1. Akduman B, Crawford ED (2001) Terazosin, doxazosin, and prazosin: current clinical experience. Urology 58:49-54
2. Anglin IE, Glassman DT, Kyprianou N (2002) Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis 5:88-95
3. Austin PF, Cook BL, Niederhoff RA, Manson SR, Coplen DE, Weintraub SJ (2004) Inhibition of mitogenic signaling and induction of apoptosis in human bladder smooth muscle cells treated with doxazosin. J Urol 172:1662-1665
4. Blouin S, Basle MF, Chappard D (2005) Rat models of bone metastases. Clin Exp Metastasis 22:605-614
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Bruckheimer EM, Kyprianou N (2000) Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 301:153-162
7. Chiang CF, Son EL, Wu GJ (2005) Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Prostate 64:408-418
8. Chichester CO, Rodgers RL (1987) Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat. J Cardiovasc Pharmacol 10:21-26
9. Chiquet M (1999) Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol 18:417-426
10. Chon JK, Borkowski A, Partin AW, Isaacs JT, Jacobs SC, Kyprianou N (1999) Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161:2002-2008
11. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
12. Cunha GR, Ricke W, Thomson A, Marker PC, Risbridger G, Hayward SW, Wang YZ, Donjacour AA, Kurita T (2004) Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92:221-236
13. Eiras S, Fernandez P, Pineiro R, Iglesias MJ, Gonzalez-Juanatey JR, Lago F (2006) Doxazosin induces activation of GADD153 and cleavage of focal adhesion kinase in cardiomyocytes en rote to apoptosis. Cardiovasc Res 71:118-128
14. Fernando MA, Heaney AP (2005) Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas. Mol Endocrinol 19:3085-3096
15. Fleisch MC, Maxwell CA, Barcellos-Hoff MH (2006) The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr Relat Cancer 13:379-400
16. Foster HE Jr, Yono M, Shin D, Takahashi W, Pouresmail M, Afiatpour P, Latifpour J (2004) Effects of chronic administration of doxazosin on alpha1-adrenoceptors in the rat prostate. J Urol 172:2465-2470
17. Garrison JB, Kyprianou N (2006) Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res 66:464-472
18. Glassman DT, Chon JK, Borkowski A, Jacobs SC, Kyprianou N (2001) Combined effect of terazosin and finasteride on apoptosis, cell proliferation and transforming growth factor-beta expression in benign prostatic hyperplasia. Prostate 46:45-51
19. Gömori G (1937) Silver impregnation of reticulum in paraffin sections. Am J Pathol 13:993-1002
20. Gosling JA (1997) Modification of bladder structure in response to outflow obstruction and ageing. Eur Urol 32:9-14
21. Huang X, Lee C (2003) Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. Front Biosci 8:740-749
22. Huysman JA, Vliegen HW, Van der Laarse A, Eulderink F (1989) Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts. Pathol Res Pract 184:577-581
23. Ilio KY, Park II, Pins MR, Kozlowski JM, Lee C (2001) Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF-beta1. Prostate 48:131-135
24. Isaacs JT (1984) Antagonist effect of androgen on prostatic cell death. Prostate 5:545-558
25. Junqueira LC, Bignolas G, Brentabi RR (1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447-455
26. Keledjian K, Garrison JB, Kyprianou N (2005) Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. J Cell Biochem 94:374-388
27. Kyprianou N (2003) Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol 169:1520-1525
28. Kyprianou N, Benning CM (2000) Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer Res 60:4550-4555
29. Kyprianou N, Isaacs JT (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562
30. Kyprianou N, Jacobs SC (2000) Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs. Curr Urol Rep 1:89-96
31. Kyprianou N, Tu H, Jacobs SC (1996) Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 27:668-675
32. Kyprianou N, Litvak JP, Borkowski A, Alexander R, Jacobs SC (1998) Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. J Urol 159:1810-1815
33. Lamb DJ, Zhang L (2005) Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression. J Nutr 135:3009-3015
34. Lee KL, Peehl DM (2004) Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 172:1784-1791
35. Martikainen P, Kyprianou N, Isaacs JT (1990) Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells. Endocrinology 127:2963-2968
36. Mauviel A (2005) Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol Med 117:69-80
37. McNeal JE (1981) The zonal anatomy of the prostate. Prostate 2:35-49
38. Nemeth HA, Lee C (1996) Prostatic ductal system in rats: regional variation in stromal organization. Prostate 28:124-128
39. Partin JV, Anglin IE, Kyprianou N (2003) Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signaling and I Kappa B alpha induction. Br J Cancer 88:1615-1621
40. Roy-Burman P, Wu H, Powell WC, Hagenkord J, Cohen MB (2004) Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer 11:225-254
41. Schuster N, Krieglstein K (2002) Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307:1-14
42. Shapiro E, Hartanto V, Lepor H (1992) The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 21:297-307
43. Steidle CP, Cohen ML, Hoover DM, Neubuer BL (1989) Comparative contractile responses among ventral, dorsal and lateral lobes of the rat prostate. Prostate 15:53-63
44. Taboga SR, Vidal BC (2003) Collagen fibers in human prostatic lesions: histochemistry and anisotropies. J Submicrosc Cytol Pathol 35:1-6
45. Thielen JL, Volzing KG, Collier LS, Green LE, Largaespada DA, Marker PC (2007) Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers. Differentiation 75:49-61
46. Turkeri LN, Ozyurek M, Ersev D, Akdas A (2001) Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia. Arch Esp Urol 54:191-196
47. Wong YC, Wang YZ (2000) Growth factors and epithelial-stromal interactions in prostate cancer development. Int Rev Cytol 199:65-116
48. Yang G, Timme TL, Park Wu X, Wyllie MG, Thompson TC (1997) Transforming growth beta 1 transduced mouse prostate reconstitution. II. Induction of apoptosis by doxazosin. Prostate 33:157-163
49. Yono M, Foster HE Jr, Shin D, Mane S, Latifpour J (2005) Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling. Life Sci 77:470-479
50. Zhu B, Kyprianou N (2005) Transforming growth factor beta and prostate cancer. Cancer Treat Res 126:157-173